Gilead Sciences

Headlines

Coronavirus Drug Could Cost 750% More Than a Flu Shot

March 6, 2020

Market News
Op-ed

Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge

February 24, 2020

Headlines
Markets
Business
Gaming
About Us
We are Hiring
SEO for Journalists
SEO for News

© 2020 CCN.com By Hawkfish AS, Drengsrudhagen 6, 1385, Asker, Norway. Former: PF Wetting. CCN.com, also known as CCN Markets, is a news site reporting on Markets, Gaming, Business, and Global Affairs. Op-eds and opinions should not be attributed to CCN.com. Disclaimer: Any financial information given on CCN.com should not be used as an investment or trading advice. Conduct your own research and due diligence before making any investment or trading decisions. Journalists and editors on CCN.com follow the Code of Ethics of the Norwegian Press. Editors follow the Rights and Duties of the Editor declaration. Chief Editor: Samburaj Das. Email: samburaj@ccn.com U.S. Editor: Josiah Wilmoth. Email: josiah.wilmoth@ccn.com Financial Editor: Sam Bourgi - sam.bourgi@ccn.com West Coast Editor: Aaron Weaver. Email: aaron.weaver@ccn.com Director and Founder: Jonas Borchgrevink. Email: jonas.borchgrevink@ccn.com HR and Recruiting: Pamela Meropiali. Email: pamela.meropiali@ccn.com Sales Manager: Pankaj Upadhyay. Email: pankaj@ccn.com. News Sitemap - RSS Feeds - Terms and Conditions - By using our site you agree to our Privacy and Cookie Policy.